Balance sheet of the liquidity contract with Natixis Oddo BHF SCA as of December 31, 2023
04 Janvier 2024 - 5:45PM
Balance sheet of the liquidity contract with Natixis Oddo BHF SCA
as of December 31, 2023
Strasbourg, January 4, 2024 – 05:45 pm CET
Under the liquidity contract entrusted by
Transgene to Natixis Oddo BHF SCA, as of December 31, 2023, the
following resources were managed through the liquidity account:
- 303,861 shares
- € 125,121.00
In the second half of 2023, a total of:
Purchases |
157,564 shares |
€ 249,580 |
651 market transactions |
Sales |
133,103 shares |
€ 219,772 |
613 market transactions |
It is recalled that when the liquidity program
was initially established in 2016, the following resources were
made available:
Cash balance of the liquidity contract: €
500,000.00 At the time the liquidity program was transferred to
Natixis Oddo BHF SCA on January 2, 2020, the resources managed
through the liquidity account consisted of:
- 164,183 shares
- € 246,158.00
Contacts
Transgene:Arnaud
DUBARRYCFO+33 (0)3 88 27 91 00investorrelations@transgene.fr |
|
- 20240104_BilanSemestriel_H2_2023_EN
Transgene (EU:TNG)
Graphique Historique de l'Action
De Mar 2024 à Avr 2024
Transgene (EU:TNG)
Graphique Historique de l'Action
De Avr 2023 à Avr 2024